CD34 and diabetes mellitus: In a study involving mice with diabetes, human endothelial progenitor cells (CD34+ cells) were injected locally into the wound bed, which led to neovascularization in conjunction with recipient endothelial cells, increased wound vascular density, and a high rate of wound closure [28].